SCHEMBL1473687

SCHEMBL1473687

O=C1C=C(c2ccccc2)C(=O)N1c1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 3/20 0.47
ALDH1A1 P00352 5/20 0.45
MAPT P10636 4/20 0.45
GAA P10253 3/20 0.45
NPSR1 Q6W5P4 3/20 0.45
CCR6 P51684 2/20 0.45
HPGD P15428 2/20 0.45
ALOX12 P18054 2/20 0.45
CACNA1B Q00975 2/20 0.45
APBA1 Q02410 2/20 0.45
FAAH O00519 1/20 0.44
THRB P10828 1/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
PGR P06401 1/20 0.40
KDM4E B2RXH2 3/20 0.39
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38
NPC1 O15118 1/20 0.37
RGS4 P49798 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1471089 0.91 MGLL (0.52) MGLLALDH1A1MAPTGAANPSR1
SCHEMBL303331 0.88 ALDH1A1 (0.51) MGLLALDH1A1MAPTGAANPSR1
SCHEMBL1471161 0.85 MAPT (0.50) MGLLALDH1A1MAPTGAANPSR1
SCHEMBL1471857 0.84 MEN1 (0.51) MGLLALDH1A1MAPTNPSR1HPGD
SCHEMBL1471763 0.84 ALDH1A1 (0.43) MGLLALDH1A1MAPTGAANPSR1
SCHEMBL28170453 0.83 NPSR1 (0.47) MGLLALDH1A1MAPTGAANPSR1
SCHEMBL1471657 0.83 MAPT (0.54) MGLLALDH1A1MAPTGAANPSR1
SCHEMBL1471136 0.83 MGLL (0.47) MGLLALDH1A1MAPTGAANPSR1
SCHEMBL28976650 0.83 ALDH1A1 (0.45) MGLLALDH1A1MAPTGAANPSR1
SCHEMBL1471189 0.83 ALDH1A1 (0.57) MGLLALDH1A1MAPTGAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111316986-B Application of maleimide compound as chitin synthetase inhibitor 浙江工业大学 2021-10-15 CN disclosed
CN-111316986-A Application of maleimide compound as chitin synthetase inhibitor 浙江工业大学 2020-06-23 CN disclosed
US-7915304-B2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT CONGENIA S.R.L. (IT) 2011-03-29 US disclosed
EP-2091531-B1 PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT CONGENIA S R L (IT) 2010-11-24 EP disclosed
US-20100099736-A1 PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT CONGENIA S.R.L. (IT) 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099736-A1 PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT CYC1, MTPN, TXN2 MGLL 857/4885ALDH1A1 800/4885MAPT 1947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.